HealthMatch is capturing clinical trials focused on or responding to challenges created by the COVID-19 pandemic. The invitation is open for any relevant clinical trials to add their information to…
Given the increased burden that COVID-19 presents across the health sector including clinical trials, the Commission together with the Chair, Professor Chris Brook and the Australian Government Department of Health…
The Australian Research Council (ARC) is also making special provisions to support researchers affected by COVID-19 including the following extensions: End of Year Reports – deadline extended from 31 March…
The NHMRC is considering changes to some due dates for 2020 in response to the COVID-19 outbreak. The minimum data due date for Synergy Grants will be extended beyond Wednesday…
In response to the pandemic, ClinTrial Refer has developed a dedicated COVID-19 app to allow all trial sites to list COVID-19 studies. This resource is being provided at no charge…
Two MRFF funding programs for COVID 19 research are now open. A $5 million respiratory medicine grant opportunity closes on 6 April 2020Respiratory Medicine Trials Research on COVID-19 Grant Opportunity An $8…
Due to the COVID-19 pandemic, changes to the accreditation requirements to the National Safety and Quality Health Service (NSQHS) Standards are being enacted. The Australian Commission on Safety and Quality…
If you are personally affected, concerned with, or at risk of getting COVID-19, or are involved in the care of those who are, Cochrane invites you to complete this 10-minute…
Alongside the national guidance released last week, the Victorian Department of Health and Human Services have released additional guidance, which will continue to be updated. This includes: Consent for COVID-19 Research Projects…
If you missed the PRAXIS webinar, Managing Clinical Trials in a time of uncertainty, it is now available as a recording. Q&As from the session will be released soon….
The FDA has updated its guidance (on 27 March 2020) to provide general considerations to assist sponsors of clinical trials. These guidelines include: Assuring the safety of trial participants; Maintaining compliance with…
This list of resources was compiled by Melissa Harden for the University of York with input from members of the NIHR Policy Research Programme Reviews Faculty. It includes COVID-19 databases,…
The Deputy editor of JAMA provides a series of recommendations on maintaining clinical trial integrity during the COVID-19 pandemic. JAMA emphasises the need for creative thinking and persistence in maintaining clinical trials. The…
One of the challenges associated with adaptive trials is ensuring that the Data Safety and Monitoring Board (DSMB) functions effectively. To help address this knowledge gap, ACTA hosted a webinar…
ACTA’s Innovative Trial Design Reference Group and STInG Leadership are heavily involved in adaptive trials and are working to ensure their professional peers can access and share their knowledge. One…
A coalition of peak Australian experts have come together to develop new ‘living guidelines’ that will provide continuously-updated, evidence-based guidance to clinicians treating people with confirmed or suspected COVID-19 infections across primary,…
The Australian Academy of Science has created a COVID-19 Expert Database so governments, the business sector, the research sector and other decision-makers can easily access experts across many fields. The…
This site offers the latest in content, correspondence and articles related to COVID-19 from across The Lancet to assist health workers and researchers. https://www.thelancet.com/coronavirus…
If you need information about, or clarification of guidance around clinical trials during COVID-19, these are your local contacts. Australian Capital Territory ACT Health Directorate Research Ethics and Governance Office…
This video, created by Adaptive Health Intelligence, explains what adaptive clinical trials are and how they differ from traditional clinical trial designs….
This video, created by Adaptive Health Intelligence, explains the benefits of adaptive trial designs to both researchers and participants….
This video, created by Adaptive Health Intelligence, explains how traditional trials calculate sample size and how adaptive sample sizes work for adaptive trial design….
This document will assist Clinical Trial Networks in establishing trial endorsement policies or guidelines….
The Australian Academy of Health and Medical Sciences (AAHMS) is running a free webinar on 29 April at 5pm, live streamed from https://aahms.org/events/covid-19-where-to-from-here-charting-a-course-for-resilience-and-recovery/. This webinar will be chaired by Prof…
ACTA Members can nominate a clinical trial that was published in 2019 for ACTA’s Trial of the Year Awards. The awards are open to ACTA Full and Associate members. Each…
ACTA has been distributing key guidance, information and resources relevant to clinical trials during the COVID-19 pandemic. COVID-19 communication has been distributed through our Newsletter list, so if you receive…
ACTA’s Efficient and Effective Clinical Trial Network (CTN) Reference Group has published a document to advise and assist CTNs developing endorsement and trial review guidelines. This document acts as a…
ACTA’s Reference Group on Innovative Trial Design held a webinar on the challenges associated with Data Safety and Monitoring Boards (DSMBs) in adaptive trial designs. The webinar was well received,…
ACTA’s Special Interest Group for Network Managers has had three new Members join in the past month, and we would like to welcome those Members on board. Welcome to Dr…
Several ACTA Member organisations including the Australasian Lung Cancer Trials Group and the Australasian Leukaemia and Lymphoma Group have endorsed an interim consensus guide for managing immunocompromised oncology and haematology…
Dear Colleagues Over the last month, several of our Members approached ACTA to consider establishing a register of clinical trials on COVID-19 in Australia. We reached out to our clinical…